Skip to Content

Clinical Trials Search Results

Showing 1-3 of 3

Sorted By:

  • Astex AT13397-05

    A Study of HSP90 Inhibitor AT13387 Alone and in Combination with Crizotinib in the Treatment of Non-small Cell Lung Cancer (NSCLC)

  • Celgene ABI-007-NSCL-003

    A Phase III, randomized, open-label, cross-over, multi-center, safety and efficacy study to evaluate nab-paclitaxel (Abraxane) as maintenance treatment after induction with nab-paclitaxel plus carboplatin in subjects with squamous cell non-small cell lung cancer (NSCLC)

  • CTSU E5508

    A Randomized Phase III Study of Maintenance Therapy with Bevacizumab, Pemetrexed, or a Combination of Bevacizumab and Pemetrexed Following Carboplatin, Paclitaxel and Bevacizumab for Advanced Non-Squamous NSCLC.

Showing trials 1-3 of 3

Also in this Section